Patents by Inventor Thomas C. Wood

Thomas C. Wood has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HERBICIDAL COMPOSITIONS AND RELATED METHODS
    Publication number: 20220000106
    Abstract: A herbicidal composition is provided that includes at least one glutamine synthetase inhibitor and at least one herbicidal fatty acid or carboxylic acid compound. Methods of burndown treatment of undesirable vegetation are also provided.
    Type: Application
    Filed: June 29, 2021
    Publication date: January 6, 2022
    Inventors: Jerry L. CORBETT, Thomas C. WOOD
  • Methods of detecting, diagnosing, and treating carotid plaque vulnerability
    Patent number: 11009514
    Abstract: Disclosed are methods of, and assay and kits for, detecting and diagnosing methods of detecting, diagnosing, vulnerable carotid artery disease capable of becoming acutely symptomatic using the levels of Resolvin D1 (RvD1), docosahexaenoic acid (DHA), and arachidonic acid (AA). Also disclosed are methods of treating carotid artery disease and methods of identifying agents for use in the treatment of carotid artery disease.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: May 18, 2021
    Assignees: OCHSNER HEALTH SYSTEM, THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURE AND MECHANICAL COLLEGE, THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
    Inventors: Hernan A. Bazan, Yan Lu, Song Hong, Zhide Fang, Bokkyoo Jun, Thomas C. Woods
  • METHODS OF DETECTING, DIAGNOSING, AND TREATING CAROTID PLAQUE VULNERABILITY
    Publication number: 20180372763
    Abstract: Disclosed are methods of, and assay and kits for, detecting and diagnosing methods of detecting, diagnosing, vulnerable carotid artery disease capable of becoming acutely symptomatic using the levels of Resolvin D1 (RvD1), docosahexaenoic acid (DHA), and arachidonic acid (AA). Also disclosed are methods of treating carotid artery disease and methods of identifying agents for use in the treatment of carotid artery disease.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 27, 2018
    Inventors: Hernan A. Bazan, Yan Lu, Song Hong, Zhide Fang, Bokkyoo Jun, Thomas C. Woods
  • Arsenic methyltransferase sequence variants
    Patent number: 7250290
    Abstract: Isolated ASMT nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described, as well as ASMT allozymes. Methods for determining if a mammal is at risk for toxicity from acute or chronic arsenic exposure also are described.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: July 31, 2007
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Bianca A. Thomae, Eric D. Wieben, Richard M. Weinshilboum, Thomas C. Wood
  • Sulfotransferase sequence variants
    Publication number: 20040235098
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described. Methods for determining a risk estimate for hormone dependent disease and methods for determining sulfonator status also are described.
    Type: Application
    Filed: September 23, 2003
    Publication date: November 25, 2004
    Applicant: Mayo Foundation for Medical Education and Research, a Minnesota corporation
    Inventors: Richard M. Weinshilboum, Rebecca B. Raftogianis, Thomas C. Wood, Diane M. Otterness
  • Sulfotransferase sequence variants
    Publication number: 20020039775
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described. Methods for determining a risk estimate for hormone dependent disease and methods for determining sulfonator status also are described.
    Type: Application
    Filed: April 10, 2001
    Publication date: April 4, 2002
    Applicant: Mayo Foundation for Medical Education and Research, Minnesota corporation
    Inventors: Richard M. Weinshilboum, Rebecca B. Raftogianis, Thomas C. Wood, Diane M. Otterness
  • Sulfotransferase sequence variants
    Patent number: 6265561
    Abstract: Isolated sulfotransferase nucleic acid molecules that include a nucleotide sequence variant and nucleotides flanking the sequence variant are described. Methods for determining a risk estimate for hormone dependent disease and methods for determining sulfonator status also are described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: July 24, 2001
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Rebecca B. Raftogianis, Thomas C. Wood, Diane M. Otterness
  • cDNA cloning and expression of human liver estrogen sulfotransferase
    Patent number: 5744355
    Abstract: The present invention provides an isolated and purified human DNA molecule that encodes human estrogen sulfotransferase.
    Type: Grant
    Filed: May 9, 1995
    Date of Patent: April 28, 1998
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Ibrahim A. Aksoy, Thomas C. Wood
  • cDNA cloning and expression of human liver estrogen sulfotransferase
    Patent number: 5714594
    Abstract: The present invention provides an isolated and purified human DNA molecule consisting essentially of a DNA segment encoding an estrogen sulfotransferase protein or biologically active derivative thereof.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: February 3, 1998
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Ibrahim A. Aksoy, Thomas C. Wood
  • Stably-transformed cells expressing human thiopurine methyltransferase
    Patent number: 5470737
    Abstract: A recombinant DNA sequence is provided which encodes human thiopurine methyl transferase (TPMT), as well as a mammalian cell line having said recombinant DNA sequence incorporated into the genome thereof, so that the cells express high levels of human TPMT activity.
    Type: Grant
    Filed: October 3, 1994
    Date of Patent: November 28, 1995
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Richard M. Weinshilboum, Ronald Honchel, Ibrahim A. Aksoy, Carol L. Szumlanski, Thomas C. Wood, Diane M. Otterness, Eric D. Wieben
  • Papermakers' felt having compressible elastomer elements and methods of producing same
    Patent number: 4851281
    Abstract: A papermakers' fabric having at least one layer of elastomeric foam to minimize the amplitude of vibration from the press roll. The elastomeric foam layer may be needled, chemically adhered, attached mechanically or adhered directly to the base fabric and the first batt layer on the paper contacting side of the fabric. A foam layer may also optionally be provided on the transport roll contacting side of the base fabric.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: July 25, 1989
    Assignee: Huyck Corporation
    Inventor: Thomas A. C. Wood